Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT04051827 · COMPLETED
Trial details
- NCT number
- NCT04051827
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-23
- Primary completion
- 2020-12-17
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.